EUVIMEDEUVIMED entdecken
Open Access

Targeted learning in observational studies with multi‐valued treatments: An evaluation of antipsychotic drug treatment safety

Jason Poulos iD, Marcela Horvitz-Lennon, Katya Zelevinsky, Tudor Cristea-Platon, Thomas Huijskens, Pooja Tyagi, Jiaju Yan, Jordi Diaz, Sharon-Lise Normand iD

Statistics in Medicine · 2024

DOI: 10.1002/sim.10003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Statistics in Medicine, 2024. Verfasst von Jason Poulos und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Antipsychotic Agents, Cardiovascular Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIMH NIH HHS, National Institute of Mental Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We investigate estimation of causal effects of multiple competing (multi‐valued) treatments in the absence of randomization. Our work is motivated by an intention‐to‐treat study of the relative cardiometabolic risk of assignment to one of six commonly prescribed antipsychotic drugs in a cohort of nearly 39 000 adults with serious mental illnesses. Doubly‐robust estimators, such as targeted minimum loss‐based estimation (TMLE), require correct specification of either the treatment model or outcome model to ensure consistent estimation; however, common TMLE implementations estimate treatment probabilities using multiple binomial regressions rather than multinomial regression. We implement a TMLE estimator that uses multinomial treatment assignment and ensemble machine learning to estimate average treatment effects. Our multinomial implementation improves coverage, but does not necessarily reduce bias, relative to the binomial implementation in simulation experiments with varying treatment propensity overlap and event rates. Evaluating the causal effects of the antipsychotics on 3‐year diabetes risk or death, we find a safety benefit of moving from a second‐generation drug considered among the safest of the second‐generation drugs to an infrequently prescribed first‐generation drug known for having low cardiometabolic risk.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antipsychotic AgentsCardiovascular DiseasesHumansComputer SimulationLikelihood FunctionsModels, StatisticalAdultObservational Studies as Topic

Stichwörter der Autor:innen

antipsychotic drugscardiometabolic riskcausal inferencemulti-valued treatmentsserious mental illnesstargeted minimum-loss based estimation

Substanzen

Antipsychotic Agents

Autor:innen und Institutionen

  • Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA.
  • RAND Corporation, Boston, Massachusetts, USA.
  • QuantumBlack, London, UK.
  • Department of Biostatistics, Harvard Chan School of Public Health, Boston, Massachusetts, USA.

ORCID-Profile: Jason Poulos, Sharon-Lise Normand

Förderung

  • NIMH NIH HHS
  • National Institute of Mental Health

Zitieren

APA

Poulos, J., Horvitz-Lennon, M., Zelevinsky, K., Cristea-Platon, T., Huijskens, T., Tyagi, P., Yan, J., Diaz, J., & Normand, S. L. (2024). Targeted learning in observational studies with multi‐valued treatments: An evaluation of antipsychotic drug treatment safety. Statistics in Medicine. https://doi.org/10.1002/sim.10003

Vancouver

Poulos J, Horvitz-Lennon M, Zelevinsky K, Cristea-Platon T, Huijskens T, Tyagi P, et al. Targeted learning in observational studies with multi‐valued treatments: An evaluation of antipsychotic drug treatment safety. Statistics in Medicine. 2024. doi:10.1002/sim.10003

BibTeX
@article{Poulos2024,
  author = {Poulos, Jason and Horvitz-Lennon, Marcela and Zelevinsky, Katya and Cristea-Platon, Tudor and Huijskens, Thomas and Tyagi, Pooja and Yan, Jiaju and Diaz, Jordi and Normand, Sharon-Lise},
  title = {Targeted learning in observational studies with multi‐valued treatments: An evaluation of antipsychotic drug treatment safety},
  journal = {Statistics in Medicine},
  year = {2024},
  doi = {10.1002/sim.10003}
}
Kostenlos starten →